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Abstract: Evaluating enzyme activity intracellularly on natural 
substrates is a significant experimental challenge in 
biomedical research. We report a label-free method for real-
time monitor-ing of the catalytic behavior of class A, B, and 
D carbapene-mases in live bacteria based on measurement 
of heat changes. By this means, novel biphasic kinetics for 
class D OXA-48 with imipenem as substrate is revealed, 
providing a new approach to detect OXA-48-like producers. 
This in-cell calorimetry approach offers major advantages in 
the rapid screening (10 min) of carbapenemase-producing 
Enterobacteriaceae from 142 clinical bacterial isolates, with 
superior sensitivity (97 %) and excellent specificity (100 %) 
compared to conven-tional methods. As a general, label-
free method for the study of living cells, this protocol has 
potential for application to a wider range and variety of 
cellular components and physiological processes. 
 
Intracellular enzyme activity is exquisitely regulated by its 
physiological environment. Evaluating the progress of enzyme 
reactions in the context of their native cellular environment is 
therefore of utmost importance to gain valuable information on 
enzyme kinetics and for early disease detection.[1] 
Enterobacteriaceae (CPE) producing carbapene-mases are 
gram-negative bacteria, including E. coli, Serratia, Klebsiella, 
and Enterobacter, that efficiently hydrolyze a C N bond in 
carbapenems (e.g., imipenem, meropenem, and ertapenem), 
making these “last resort” antibiotics ineffective  
 
for treating infections caused by multi-drug resistant patho-
gens.[2] Carbapenemases have been classified into A, B, and D 
groups by the Ambler system, according to amino acid 
homologies.[3] Classes A and D are composed of serine b-
lactamases, which cleave the b-lactam with the formation of an 
acyl–enzyme intermediate. The most prevalent ones in clinic are 
K. pneumoniae carbapenemase (KPC) in Class A and 
oxacillinase-48 (OXA-48) in Class D. Class B carbape-nemases 
are metallo-b-lactamases, which require zinc for catalysis, 
including New Delhi metallo-b-lactamase (NDM-1) and 
imipenem-hydrolyzing lactamase (IMP) (Figure 1 a). These 
carbapenemase genes are often plasmid-encoded and can readily 
be transmitted to other pathogenic species, provoking nosocomial 
outbreaks or epidemics. Given the high morbidity and mortality 
caused by it, CPE has become one of today s most serious public 
health threats worldwide.[4] As a consequence, kinetic 
investigations of carbapenemase reaction are being pursued 
intensively in biomedical fields.  
Real-time characterization of carbapenemase activity in 
living bacteria is accepted as crucial for mechanistic studies and 
rapid CPE detection. Intracellular hydrolytic activity of  
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Figure 1. a) Schematic of experimental procedure. b) Thermograms of 
reaction, after injecting 28 mL of 5 mm imipenem, or buffer, into  
a calorimetric cell loaded with 210 mL of living KPC-Kp suspensions 
at OD600 =4. c) Thermograms of injection of imipenem into bacterial 
suspensions (ESBL-Kp and AmpC-Kp) and into 50 nm KPC protein.  
d) Thermograms of the hydrolysis of imipenem by KPC-Kp in the  
absence and presence of 500 mm EDTA or 1 mm sulbactam. All 
experiments were prepared in 50 mm Tris-HCl, pH 7.6, 0.1 mm 
ZnCl2 at 25 8C. 
 
 
  
 
 
b-lactamases has been studied using UV spectroscopy,[5] 
MALDI-TOF MS,[6] and NMR spectroscopy.[7] These meth-ods 
are not widely applicable because of signal interference with 
turbid bacterial suspensions or with specific substrates (e.g., 
cephalosporins are incompatible with in-cell NMR spectroscopy), 
inoperability of continuous recording the course of enzymatic 
reactions, requirements for special sample preparation (e.g., 
deuterium labeling), or require-ments for expertise in data 
handling. Chromogenic and fluorogenic probes have been 
developed to overcome these impediments and facilitate analysis 
of b-lactamase activity in complex biological systems,[8] 
although, the changed specific-ity and kinetic properties of 
labeled substrates from those of natural ones remains a concern. 
Hence, there is a major need for a sensitive and uncomplicated 
approach for real-time monitoring of the activity of cellular 
carbapenemase activity using label-free, native substrates. 
 
Heat changes are fundamental in all biological processes. 
Owing to the direct correlation between reaction rate and the rate 
of heat change from bond formation/breaking, reaction 
calorimetry has become a powerful tool for monitoring progress 
of enzyme reactions with natural substrates.[9] Although 
calorimetric real-time monitoring of the course of reaction yields 
accurate and significant data more rapidly than do classical 
kinetic techniques, the use of heat to study intracellular enzyme 
catalysis in living systems is still rare, largely because of concern 
over whether it can differentiate heat of reaction from background 
heat changes. We have shown that energies involved in breaking 
a b-lactam bond for metallo-b-lactamases are approximately 15–
32 kcal mol 1.[10] Because of the large enthalpy of b-lactam 
hydrolysis and the high efficiency of b-lactamases, the progress of 
micromolar b-lactam turnover (minutes) could easily be followed 
using a modern calorimetry instrument (signal noise < 0.01 mcal s 
1) at nanomolar concentration of enzyme. By contrast, meta-bolic 
heat derived from cell growth often takes place over a much 
longer period of time (hours to days),[11] and binding heat is 
known to be several orders of magnitude lower than reaction 
heat.[12] Given the substrate specificity of b-lacta-mases and 
significant heat changes in b-lactam catalysis, we anticipated that 
in situ b-lactamase activity in living bacteria could be probed 
accurately by tracking heat changes during turnover of an 
exogenous b-lactam under controlled condi-tions (Figure 1 a). In 
this work, we develop an in-cell calorimetry assay to investigate 
the real-time reaction prog-ress of Class A, B, and D CPE with 
imipenem, providing more direct and accurate data on the 
catalytic behavior of carbapenemases in live bacteria. We further 
explore its use in rapid identification of CPE in clinical samples. 
 
 
We first tested in situ thermal monitoring of carbapene-mase 
activity in a calorimetry experiment using a KPC-producing K. 
pneumoniae strain (KPC-Kp; ATCC-1705) as reference. 
Titrating imipenem solution (588 mm in 50 mm Tris-HCl, pH 
7.6, 0.1 mm ZnCl2) into living KPC-Kp suspensions (OD600 = 
4.0 in the same buffer; corresponding to approx-imately 57 nm 
KPC protein based on SDS-PAGE analysis of bacterial lysate) 
results in an instant negative change in heat-flow, showing the 
reaction is exothermic (Figure 1 b, blue curve). To make sure that 
the heat detected is from reaction 
 
 
 
inside the bacteria, KPC-Kp suspensions were spun down and the 
supernatant was used in a repeat experiment. The data show only 
negligible heat change with the supernatant solution (Figure 1 b, 
orange curve). Additional control experi-ments by injecting 
buffer into living KPC-Kp suspensions (Figure 1 b, black curve), 
injecting imipenem into two carba-penemase-negative bacterial 
suspensions (ESBL-Kp, Fig-ure 1 c green curve; AmpC-Kp, 
Figure 1 c orange curve) and injecting imipenem into buffer 
(Figure 1 c, black curve) show no heat contributions from 
metabolic heat, nonspecific bind-ing to cellular components, or 
dilution heat. Under the experimental conditions employed, the 
amplitude of heat  
change (DP) and the apparent enthalpy change (DHapp) for 
imipenem with KPC-Kp is at least 12-fold and 40-fold higher  
than background signals. To further confirm that the observed 
heat changes with KPC-Kp primarily result from enzyme 
catalysis, the calorimetry experiment was performed by titrating 
imipenem into a 50 nm purified KPC protein solution (Figure 1 c, 
blue curve). As expected, the features of the calorimetric trace 
with KPC-Kp resemble those of KPC protein, both indicating a 
constant phase of the thermal power over several minutes (150 to 
275 s), representing initial velocities at saturating conditions 
followed by a decay curve (275 to 600 s) showing gradual 
depletion of imipenem,  
reaching complete consumption at 700 s. The values of 
DHapp   are  also comparable  for bacterial suspensions 
(DHapp = 25  0.6 kcal mol 
1)  and protein (DHapp = 23 
1.2 kcal mol 1), showing that bacteria cause no observable heat 
changes under the conditions tested.  
To further verify that the heat change observed with KPC-Kp 
arises specifically from KPC activity, experiments were repeated 
in the presence of sulbactam, an effective inhibitor of Class A 
carbapenemases, or EDTA, a strong metal-chelator and inhibitor 
for Class B enzymes.[13] As expected, the observed heat with 
imipenem (Figure 1 d, blue curve) is abolished in the presence of 
1 mm sulbactam (Figure 1 d, green curve), whereas 500 mm 
EDTA (Figure 1 d, black curve) shows negligible effect on the 
thermograms of KPC-Kp with imipenem. Further inhibitory 
results using a clinical E. coli isolate encoding Class B NDM-1 
(NDM-1-E. coli), a clinical isolate harboring both KPC and IMP 
enzymes (KPC/IMP-Kp), and a reference K. pneumoniae strain 
expressing Class D OXA-48 (OXA-48-Kp, NCTC-13442) also 
agree well with the inhibitory profiles of these enzymes, 
confirming that the heat change curves specifically reflect the 
progress of enzymatic hydrolysis of imipenem in live bacteria 
(Supporting Informa-tion, Figure S1). 
 
A distinct biphasic calorimetric progress curve is observed 
with OXA-48-Kp (Figure 2 a, black curve). In this case, a short 
fast exothermic peak lasting circa 100 s accounts for most of the 
reaction, then changes to a much slower steady-state curve that 
lasts for 500 s at a steady rate until all substrate is consumed. 
Carbamylation of a conserved lysine in some OXAs, formed by 
the reaction of carbon dioxide and the non-protonated e-amino 
group of this lysine, is crucial for hydrolysis of some specific b-
lactams.[14] While several crystal structures of OXA-48 
confirmed the presence of an N-carbamylated lysine,[15] the 
effect of lysine carbamylation on carbapenem hydrolysis remains 
unresolved. To investigate 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The biphasic kinetics of OXA-48 with imipenem (IMI).  
a) Effect of added CO2 derived from sodium bicarbonate on the 
catalytic activity of OXA-48 with imipenem in a calorimetry assay 
using living OXA-48-Kp suspensions and b) a UV-
spectrophotometric assay using OXA-48-Kp lysates. 
 
 
whether the slow phase in the calorimetry assay with OXA-48-Kp 
suspension is a result of enzyme deactivation, experi-ments were 
performed with added bicarbonate as a source of carbon dioxide 
to facilitate lysine carbamylation. Increasing bicarbonate from 10 
to 50 mm causes the slow secondary phase to be progressively 
subsumed into the initial fast phase (Figure 2 a, orange and blue 
curves). The UV-spectroscopic assay also confirms the effect of 
bicarbonate on the hydrolytic activity of OXA-48 with imipenem 
(Figure 2 b; supernatant of OXA-48-Kp lysate is used to avoid the 
interference of bacterial suspensions in UV readings). It is notable 
that the biphasic feature observed in the calorimetry assay in the 
absence of bicarbonate is barely visible in the UV-spectro-scopic 
assay, which highlights the much greater sensitivity of the 
calorimetry approach. This distinction is likely due to the 
calorimetry method using a differential rate method as opposed to 
the integrated rate analysis of the UV assay, hence the change in 
reaction rate is more clearly identified. 
 
Next, we evaluated the dose-dependent effect of carba-
penemases on reaction thermograms, by recording heat-flow on 
injecting imipenem (final concentration, 588 mm) into 2-fold 
serial dilutions of the above-mentioned reference bacterial 
suspensions (Figures 3 a and Figure S2a,d). The amplitude of 
thermal power (DP) is considered as enzyme activity and is in a 
linear relation to bacterial density, in the  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Comparison of in-cell calorimetry with Carba-NP test for 
sensitivity in detecting carbapenemase activity using live bacteria of 
KPC-K. pneumonia at given concentrations. a) Raw calorimetric data 
using 588 mm imipenem as substrate, and linear dependence of heat 
change rate (DP) on bacterial density. b) Dependence of results on 
bacterial density in Carba-NP test, using both 588 mm (black squares) 
and 20 mm imipenem (cyan triangles). 
 
 
 
range of OD600 of 0.06–4.0 for KPC-Kp (Figures 3 a), 0.03–4.0 
for NDM-1-E. coli (Figures S2b) and 2–8 for OXA-48-Kp  
(Figures S2 e). Similar experiments were repeated using pure 
recombinant carbapenemases, from which the detection limit was 
estimated to be lower than 3 nm for KPC/NDM-1 and 19 nm for 
OXA-48 (Figure S3). These results indicate that the DP values in 
the calorimetry assay quantitatively reflect intracellular 
carbapenemase with high sensitivity and have potential to be used 
for rapid CPE detection. Currently, the Carba-NP test is the only 
carbapenemase activity-based colorimetric assay suggested by 
Clinical and Laboratory Standards Institute (U.S.) for CPE 
detection.[16] To demon-strate the advantages of the in-cell 
calorimetry assay, an updated Carba-NP assay was used for direct 
comparison. However, neither of the three strains show an 
apparent change of color at 588 mm imipenem (Figure S4 a). 
With a 30-fold larger substrate concentration, positive results for 
this updated Carba-NP assay are obtained with bacterial suspen- 
 
sions with OD600 values as low as 2 for KPC-Kp (Figure 3 b and 
Figure S4 b), 0.12 for NDM-1-E. coli (Figures S2 c and  
S4 c), while OXA-48-Kp is still not detected at OD600 of 16 after 
120 min (Figures S2 f and S4 d). This is not surprising  
since Carba-NP assay has been reported to have difficulties with 
OXA-48 producers.[17] Considering the difference in substrate 
concentration between the two assays, the in-cell calorimetry 
assay is at least two orders of magnitude more sensitive than the 
updated colorimetric assay, with the advantages of a significantly 
shorter testing time ( 10 min) and ability to provide fingerprint 
thermograms for OXA-48-producers. 
 
Timely detection of CPE is regarded as one of the key 
approaches to prevent rapid spread of resistant strains and to 
guide clinical treatment.[4] Having demonstrated the specific-ity, 
sensitivity, and rapidity of the in-cell calorimetry approach in 
detecting carbapenemase in live bacteria, we sought to apply it to 
the screening of clinical CPE and to compare its performance 
with current phenotypic tests. For this purpose, a collection of 
142 clinical Enterobacteriaceae strains were included in the 
study. Of these, 97 are identified as CPE and 45 are non-CPE 
(Tables S1 and S2).[3a, 18] In-cell calorimetry tests were 
performed on these isolates as described above, and results were 
evaluated by extracting DP and DH values from calorimetric data 
for analysis using logistic regression models. The regression 
coefficient of DP in the model is statistically significant (P = 
0.029), suggesting that intracellu-lar carbapenemase activity is 
well reflected by DP values. The cut-off value of DP determined 
by the decision-tree model is 1.1. Using this cut-off value, the 
calorimetry assay successfully detects 94 of 97 CPE within 10 
min of each test, while all the non-carbapenemase producers are 
correctly determined (Fig-ure 4 a,b). The results give a sensitivity 
of 97 % and a specific-ity of 100 % for the calorimetry test 
(Figure 4 c). The three samples that fail the in-cell calorimetry 
test are IMP-producers (2 strains of IMP-4 and 1 strain with an 
unknown subtype of IMP; Figure 4 b) and have a low level of 
resistance to imipenem (MICs in the range 0.25–8 mg L 1). It is 
possible that the enzyme expression level/activity in these strains 
may be too low for ready detection. 
 
 
                            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. In-cell calorimetry assay results compared to older methods 
on the detection of CPE using 142 clinical isolates. a) Distribution of 
calorimetry results using log(DH) and log(DP) values. Carbapene-
mase-positive samples are labelled “+” and carbapenemase-negative 
samples are labelled “ ”. The cut-off value for log(DP) (red dash line) is 
determined by a decision tree model. b) Distribution of the log(DP) 
values based on enzyme type for all clinical isolates. c) Comparison of 
in-cell calorimetry assay with Carba-NP, mCIM, MHT, and MIC 
methods in sensitivity, specificity, and testing time for CPE screening.  
 
The results of the in-cell calorimetry tests were then 
compared to those of an updated Carba-NP test, a modified 
carbapenem inactivation method (mCIM) test, a modified Hodge 
test (MHT) test, and a minimum inhibitory concen-tration (MIC) 
assay following reported procedures (Fig-ure 4 c).[16b, 19] The in-
cell calorimetry test shows the best sensitivity (97 %) and 
specificity (100 %) with our collection of isolates, followed by 
Carba-NP (89.9 % and 100 %), mCIM (95 % and 95.4 %), MHT 
(89.9 % and 83.7 %) and MIC (88.6 % and 68.9 %). Regarding 
the experimental duration, from availability of bacterial colonies 
on agar plates (ca. 16– 18 h), the in-cell calorimetry test delivers 
results within 10 min of the reaction owing to the real-time nature 
of the method. This is a great reduction in testing time compared 
to visual interpretation of color change in Carba-NP (2 h) or 
assessment of bacterial growth in mCIM (12 h), MHT (12 h), and 
MIC (36 h). Other features that make the calorimetric method 
preferable include ease of sample preparation, potential for 
automatic operation (commercial calorimeters are capable of 
running 384 samples unattended), and interpretation of results. 
 
 
Although we have used bacterial colonies in this screen-ing, 
the in-cell calorimetry approach is also applicable to bacteria 
directly recovered from blood culture bottles (Fig-ure S5). The 
presence of blood cells and debris does not interfere with reaction 
heat signals, avoiding the need to purify microorganisms from 
positive blood cultures. The above experiments show that the 
bacterial load required for the calorimetric approach is 
approximately 106 to 108 bacteria for the successful identification 
of CPE. There should be enough bacteria in positive blood culture 
samples identified by an automatic blood culture detection 
system, such as BACTEC FX (Becton Dickinson, USA). Hence, 
compared to 
 
the conventional susceptibility methods, the use of the in-cell 
calorimetry test directly on positive blood cultures has the 
potential to reduce the time for identification of CPE in blood 
stream infections by at least one day. Such a reduction in time is 
critical for survival of sepsis patients, as rapid initiation of 
effective antimicrobials in the first hours of sepsis is essen-
tial.[20] While this study only focuses on early identification of 
CPE, it is of note that other mechanisms may also contribute to 
carbapenem resistance in Enterobacteriaceae, such as defect in 
membrane permeability, efflux pump, and mutations on target 
proteins. When these mechanisms are present, integration of this 
in-cell calorimetry test with other tradi-tional tests (e.g., MIC 
assay) may offer a more robust strategy for more efficient 
prevention of nosocomial outbreaks and better guidance on 
antibiotic treatment.  
In conclusion, we demonstrate in detail that heat changes can 
be exploited as a label-free approach to track intracellular 
carbapenemase activity in living organisms. This approach 
features high selectivity and sensitivity for all major carbape-
nemases. Since there is currently no specific inhibitor for Class D 
carbapenemases, the characteristic biphasic thermo-grams with 
OXA-48 may provide a new approach for detecting the OXA-48-
like producers. We further demon-strate the applicability of this 
technique in very fast identifi-cation of clinical CPE with greatly 
improved accuracy as compared to conventional phenotypic 
methods. Although we have exemplified the advantages of 
utilizing heat changes to quantify enzyme activities in living 
pathogens, the concept of in-cell calorimetry is simple and should 
readily be applicable in other areas that need to characterize 
enzyme activity in complex biological systems (e.g., tumor cells, 
immune cells, and vesicles) and for a wider range of applications, 
such as monitoring abnormal enzyme activity in tumors, 
evaluating new inhibitors, and synthetic biology. 
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